Searchable abstracts of presentations at key conferences in endocrinology

ea0029p1186 | Obesity | ICEECE2012

Insulin resistance and acne: a new risk factor for men?

Del Prete M. , Faggiano A. , Mauriello M. , Di Somma C. , Monfrecola G. , Fabbrocini G. , Colao A.

Introduction: Acne is a common skin disease that occasionally can be influenced by endocrine abnormalities. In females, a clear relationship has been highlight between acne onset and peripheral insulin resistance and hyperinsulinemia, whereas few data are available in male. The aim of this study was to investigate the relationship between acne and insulin resistance as well as other metabolic impairment in male subjects with acne.Methods/design: Twenty-t...

ea0029p1572 | Thyroid (non-cancer) | ICEECE2012

Gestational hyperthyroidism in women from mild to moderate iodine deficiency (ID) areas

Presti S. , Moleti M. , Di Bella B. , Sturniolo G. , Di Mauro F. , Trimarchi F. , Vermiglio F.

Graves’ disease (GD) and gestational transient thyrotoxicosis (GTT) are the main causes of hyperthyroidism in pregnancy, their prevalence ranging between 0.1–0.4% and 0.3–11%, respectively.Aim of the study: To evaluate both prevalence and outcome of gestational hyperthyroidism in mild to moderate ID areas.Subjects and methods: 482 consecutive pregnant women who had never undergone thyroid function evaluation before a...

ea0011oc8 | Signal transduction OC1 Novartis Oncology Young Investigator Award | ECE2006

Role of the calcium-calmodulin dependent kinase II in oncogenic Ras-induced proliferation

Cavallo AL , Illario M , Di Vito E , Monaco S , Fenzi G , Rossi G , Vitale M

Activation of the Ras/ERK pathway and stimulation of proliferation by integrins in thyroid cells requires CaMKII activation. To date, whether this role of CaMKII is a general mechanism or is restricted to integrin signalling is unknown. As oncogenic activation of the Ras/ERK pathway by mutated Ras, RET/PTC and Trk is frequent in papillary thyroid carcinoma (PTC), we investigated the expression and activation level of CaMKII in PTC primary culture and in stable cell lines.<...

ea0029p1767 | Thyroid cancer | ICEECE2012

Differentiated carcinoma in dysembriogenetic thyroid lesions

Sturniolo G. , Violi M. , Presti S. , Moleti M. , Di Bella B. , Di Mauro F. , Trimarchi F. , Vermiglio F.

The prevalence of differentiated thyroid carcinoma (DTC) in lingual thyroid (LT) and thyroglossal duct cysts (TDC) is around 1%. Nowadays, almost 200 cases of DTC were reported in TDC and <60 cases in LT. Here we report four cases of neoplasia in LT (1/4) and TDC (3/4) in a consecutive series of 950 DTC patients (0.4%).Case 1: D.F. 63 year-old woman with thyroid follicular carcinoma in ectopic gland located at her tongue’s basis. March 2009: the...

ea0029p1797 | Thyroid cancer | ICEECE2012

Papillary thyroid carcinoma with high percentage of BRAFV600E alleles have a higher recurrence rate

Guerra A. , Fugazzola L. , Marotta V. , Cirillo M. , Di Stasi V. , Volpe A. , Murino A. , Di Stasi M. , Vitale M.

Context: Although unexplained conflicting results are present in the literature, most of studies report the association of BRAFV600E in papillary thyroid carcinoma (PTC) with a more advanced disease and with a worst prognosis. We recently demonstrated that in most of the cases PTC consists of a mixture of tumour cells with wild-type and mutant BRAF. Hence, we examined the association of percentage of BRAFV600E alleles with clinicopathologic parameters at diagnosis and disease ...

ea0029p1220 | Obesity | ICEECE2012

Local inflammatory response in adipose tissue dysfunction

Cantini G. , Francalanci M. , Di Franco A. , Baglioni S. , Poli G. , Samavat J. , Querci V. , Liotta F. , Perigli G. , Lucchese M. , Forti G. , Luconi M.

Chronic low-grade inflammatory condition is associated with metabolic pathologies such as obesity. However, the role exerted by local inflammation occurring in different fat depots, such as subcutaneous (SAT) versus visceral (VAT) adipose tissue (AT), is still under evaluation. Aim of the present study was to characterize the inflammatory state in adipose tissue of obese (OB: n=58, mean±S.D. BMI=47±9) vs normoweight (NOR: n=28, mean±...

ea0029p1379 | Pituitary Clinical | ICEECE2012

Epidemiology, histophatological characteristics and clinical manifestations of aggressive pituitary tumors, evaluated on the basis of KI-67 immunostaining: a single center experiense

Grasso L. , De Angelis M. , Di Somma C. , Savanelli C. , Galdiero M. , Cozzolino A. , Cavallo L. , Cappabianca P. , Del Basso De Caro M. , Pivonello R. , Colao A.

Aggressive pituitary tumors are classically defined as pituitary tumors with large size, rapid growth and massive invasion of surrounding anatomical structures. This is a group of pituitary tumors with biological behavior between pituitary adenomas and carcinomas and includes a new group of pituitary tumor, defined atypical adenoma, characterized by the presence of invasive growth and combination of increased mitotic activity and a Ki-67 labeling index >3%. The aim of this...

ea0029p1484 | Pituitary Clinical | ICEECE2012

Evaluation of bone mass and fracture in patients with prolactinoma

Guerra E , Rubino M , Di Sarno A , Vuolo L , Contaldi P , Scarano E , Brunelli V , Grasso L , Lombardi G , Colao A , Di Somma C

Patients with hyperprolactinemia have impaired bone metabolism and bone mineral density (BMD) partially represents bone’s health.To evaluate vitamin D levels, PTH, Ca and P, BMD and bone morphometry in patients with prolactin-secreting pituitary adenomas.Forty-four patients (30 W, 40±11 years, BMI 27.6±5 kg/m2) underwent to lumbar and femoral DEXA, to vertebral morphometry by X-ray and was calculated the S...